PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.53%
Revenue growth at 50-75% of MCHP's 10.82%. Martin Whitman would worry about competitiveness or product relevance.
-4.88%
Negative gross profit growth while MCHP is at 15.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
-115.79%
Negative EBIT growth while MCHP is at 140.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-115.79%
Negative operating income growth while MCHP is at 132.00%. Joel Greenblatt would press for urgent turnaround measures.
-163.64%
Negative net income growth while MCHP stands at 87.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-220.00%
Negative EPS growth while MCHP is at 70.34%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-220.00%
Negative diluted EPS growth while MCHP is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.25%
Share count expansion well above MCHP's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.25%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
-4.40%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-112.40%
Negative OCF growth while MCHP is at 33.85%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-101.65%
Negative FCF growth while MCHP is at 34.43%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
29.67%
10Y revenue/share CAGR at 50-75% of MCHP's 51.09%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
29.67%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
12.58%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
92.23%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
92.23%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
-111.86%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.31%
3Y dividend/share CAGR at 50-75% of MCHP's 81.65%. Martin Whitman might see a weaker short-term approach to distributing cash.
19.82%
AR growth well above MCHP's 10.99%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.34%
We show growth while MCHP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.77%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.22%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
16.84%
We have some new debt while MCHP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
1.94%
SG&A declining or stable vs. MCHP's 4.80%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.